Fifth Dimension    Site Map    Search    Contact Us
Cancer Supportive and Survivorship Care Improving Quality of Life Logo

Advanced Search
SiteMap

RC271.A
Chemotherapy, Cognitive, Nausea, Vomiting Issues and Drug Assistance Programs
Alexandra Andrews

RC271C - Chemotherapy Toxicities And Other Issues On Drugs Used In Oncology and Drug Assistance Programs



Chemotherapy Toxicities And Other Issues On Drugs Used In Oncology and Drug Assistance
Back to the Table of Contents


RC271.C5.F81.1 - Mental (Cognitive) Changes in Survivors
Patricia Fobair, LMSW, MPH
Survivors should know that mental impairment called chemo-brain could happen. There is little doubt that even subtle cognitive problems can be a real complication of hormone manipulations, chemotherapy, radiation and biologic response modifiers.
http://www.cancersupportivecare.com/Survivor/cognitive.html First appeared 2007-12-12; updated 2008-08-02
RC271.C5.I91.1 - Preventing Chemotherapy Toxicities And Other Issues On Drugs Used In Oncology
Dr. Robert Ignoffo, PharmD, Clinical Professor, UCSF, Zoe Ngo, PharmD, and Julie Schwenka, PharmD, UCSF
Nausea and vomiting are common side effects of chemotherapy drugs that are used to treat cancer. Some chemotherapy drugs are worse offenders than others In most cases, patients will be given anti-vomiting (antiemetics) and anti-nausea medication
http://www.cancersupportivecare.com/chemotherapy.html
First appeared 2000-06-12; updated 2007-07-08
RC271.C5.I91.2 - Drug Assistance Programs from Pharmaceutical Companies
Dr. Robert J. Ignoffo, Clinical Professor, UCSF and Jean Longtin, PharmD, UCSF
Most pharmaceutical companies run programs aimed to facilitate the accessibility to needed medications for patient who are in financial difficulties and are not eligible for Medicare, Medicaid or private insurance
http://www.cancersupportivecare.com/drug_assistance.html
First appeared 2000-06-12; updated 2007-07-08
RC271.C5.R39.1 - Antioxidants and Chemoradiotherapy
Ernest H. Rosenbaum, MD
Clinical evidence suggests that the antioxidants may reduce the effectiveness of chemotherapy a few percentage points, which could relate to a large number of potential deaths because of the reduction in therapeutic activity.
http://www.cancersupportivecare.com/antioxidant.html
First appeared 2007-02-25; updated 2007-08-18
RC271.C5.R39.2 - Cancer Treatment Side Effects and Solutions
Ernest H. Rosenbaum, MD
Cancer patients who have received radiation or cardiopulmonary toxic chemotherapy drugs merit long-term follow up. Includes information about Chemotherapy-related Cardiac Toxicity, Radiation Therapy-related Cardiac and Pulmonary Toxicity, Renal (Kidney) Toxicity Side Effects Prevention of Cardiopulmonary Side Effects and The Need for Long-term Surveillance
http://www.cancersupportivecare.com/Survivor/comorbid.html
First appeared 2007-12-30; updated 2008-08-02
RC271.C5.R150.1 - Does Adjuvant Chemotherapy for Breast Cancer Cause Cognitive Dysfunction?
Hope S. Rugo, MD
Importance of Understanding Cognitive Deficits Due to Cancer Therapy. A challenge facing cancer survivors as identified by the National Coalition for Cancer Survivorship
http://www.cancersupportivecare.com/chemobrain.pdf
First appeared 2005-11-06; updated 2008-03-04
RC271.C5.R150.2 - Does Adjuvant Chemotherapy for Breast Cancer Cause Cognitive Dysfunction?
Hope S. Rugo, MD
Importance of Understanding Cognitive Deficits Due to Cancer Therapy. A challenge facing cancer survivors as identified by the National Coalition for Cancer Survivorship
http://www.cancersupportivecare.com/chemobrain.html
First appeared 2005-11-06; updated 2008-03-04


You are welcome to share this © article with friends, but do not forget to include the author name and web address. Permission needed to use articles on commercial and non commercial websites. Thank you.


Card Catalog Site Map  |  Site Index  |  Search CancerSupportiveCare.com  |  Contact Us  |  Books  |  Top
First appeared January 31, 2007; updated August 6, 2011